Oncology & Cancer

Novel combination therapy shows strong response in phase 1 trial

A phase 1 clinical trial testing a novel combination therapy developed by scientists at VCU Massey Cancer Center slowed the growth of cancer in the majority of trial participants, which were patients with advanced solid tumors. ...

Diseases, Conditions, Syndromes

Researchers create genetic blueprint of cunning tuberculosis bacteria

The rise in multi-drug resistant (MDR) and extremely drug resistant (XDR) strains of Mycobacterium tuberculosis (MTB) is becoming a major cause of global health concern for treating tuberculosis, which affects a third of ...

Diseases, Conditions, Syndromes

Combination therapy cures tick-borne illness in mice

A novel combination therapy cures an emerging infectious disease, babesiosis, which is transmitted by the same ticks that transmit the agents of Lyme disease, said Yale researchers. This "radical" therapy not only clears ...

HIV & AIDS

HIV infection prematurely ages humans by an average of five years

Thanks to combination antiretroviral therapy, many people with HIV can be expected to live decades after being infected. Yet doctors have observed that these patients often show signs of premature aging. Now a study published ...

Diseases, Conditions, Syndromes

Curbing malaria resistance with multiple therapies

In order to preserve first-line drugs for treating malaria, multiple combination therapies should be deployed within a population to prevent resistance from developing, according to Maciej Boni from the Centre for Tropical ...

page 28 from 40